Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01392027 · ClinicalTrials.gov registry record · NA
Biospecimens for Identification of Diseases of the Pancreas.
A NA study of Pancreatic Cancer and Chronic Pancreatitis, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 712
- Enrollment target
- 1
- Study location
NCT01392027 is a NA study of Pancreatic Cancer and Chronic Pancreatitis that has completed, run by University of Michigan. The registered enrollment target is 712 participants, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01392027, a NA study of Pancreatic Cancer and Chronic Pancreatitis, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 712 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed project is designed to collect data and specimens from patients/subjects presenting to the University of Michigan with a disease affecting the pancreas (or specific control populations). This protocol is focused on collecting data, blood samples, and tissue on subjects with pancreatic diseases, including pancreatic cancer, pancreatic cysts, pancreatitis, diabetic controls, jaundice/biliary obstruction controls, and otherwise healthy controls. We are collecting up to 50 mls of blood for research purposes only. Plasma, serum and buffy coat are collected and stored according to strict SOPs.
Conditions Studied
Interventions
- PROCEDURE Blood Draw
Study Locations (1)
Michigan
- Univerisity of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 712 participants |
| Start Date | 2011-04 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01392027
The ClinicalTrials.gov registry entry for NCT01392027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 712 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (82% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood Draw is the first listed.
NCT01392027 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01392027 about?
NCT01392027 is a clinical study titled "Biospecimens for Identification of Diseases of the Pancreas.". This proposed project is designed to collect data and specimens from patients/subjects presenting to the University of Michigan with a disease affecting the pancreas (or specific control populations). This protocol is focused on collecting data, blood samples, and tissue on subjects with pancreatic ...
What is the current status of trial NCT01392027?
This trial is currently completed. It is a NA study. The enrollment target is 712 participants. The study started on 2011-04. Estimated completion is 2017-08-31.
What conditions does trial NCT01392027 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Chronic Pancreatitis, Type II Diabetes, Healthy Control, Pancreatic Cysts.
What interventions are being tested in trial NCT01392027?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT01392027?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01392027 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.